HomeNewsIndiaWHO redflags counterfeit Covishield vaccines circulation in India, Uganda

WHO redflags counterfeit Covishield vaccines circulation in India, Uganda

WHO said fake COVID-19 vaccines should be identified and weeded out as they pose a serious risk to global public health and place an additional burden on vulnerable populations and health systems.

August 18, 2021 / 15:00 IST
Story continues below Advertisement
Counterfeit drugs and vaccines are a major problem in South Asia and Africa. WHO has expressed concern about fake vaccines in circulation. (Representative image)
Counterfeit drugs and vaccines are a major problem in South Asia and Africa. WHO has expressed concern about fake vaccines in circulation. (Representative image)

The World Health Organisation (WHO) has issued a Medical Product Alert about counterfeit Covishield vaccines circulating in India and Uganda.

The falsified products were reported to WHO in July and August 2021.

Story continues below Advertisement

"The genuine manufacturer of Covishield (Serum Institute of India Pvt. Ltd.) has confirmed that the products listed in this alert are falsified. These falsified products have been reported at the patient level in Uganda and India," WHO said.

WHO said the products were confirmed as falsified on the basis that they deliberately/ fraudulently misrepresent their identity, composition or source.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show